18 research outputs found
AR4 PSYCHOMETRIC PROPERTIES OF THE ACUTE BRONCHITIS SYMPTOM SEVERITY SCALE IN AN INTERNATIONAL SAMPLE
Get PDFAR3 MOXIFLOXACIN IV/PO MONOTHERAPY IS COST-EFFECTIVE TO THE GERMAN AND FRENCH HEALTHCARE SYSTEMS WHEN COMPARED TO IV/PO AMOXICILLIN/CLAVULANATE ± CLARITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
Get PDFPDB8 A Systematic Review and Network Meta-Analysis of Second-Line Anti-Diabetes Treatments for Those with Type 2 Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy
Get PDFPsychometric evaluation of the CAP-Sym questionnaire: A new, patient-based measure of symptoms in community acquired pneumonia
Get PDFRS3: PSYCHOMETRIC EVALUATION OF THE CAP-SYM QUESTIONNAIRE: A NEW, PATIENT-BASED MEASURE OF SYMPTOMS IN COMMUNITY ACQUIRED PNEUMONIA
No full text
AR3 MOXIFLOXACIN IV/PO MONOTHERAPY IS COST-EFFECTIVE TO THE GERMAN AND FRENCH HEALTHCARE SYSTEMS WHEN COMPARED TO IV/PO AMOXICILLIN/CLAVULANATE ± CLARITHROMYCIN IN THE TREATMENT OF COMMUNITY-ACQUIRED PNEUMONIA
No full textAR4 PSYCHOMETRIC PROPERTIES OF THE ACUTE BRONCHITIS SYMPTOM SEVERITY SCALE IN AN INTERNATIONAL SAMPLE
No full textAnticoagulation Treatment with VKA in France, Italy, Germany, Spain and United Kingdom. Results from the React AF Study
No full text
